Not just another value proposition
Pharma faces fast changes around value and real-world evidence. They must gain access to relevant data at the right time, fulfil payer’s needs, grow patient engagement, implement new approaches and technologies, whilst saving money.
eyeforpharma spoke with Teva, Otsuka, CSL Behring, and several more to hear how to manage these expectations whilst providing data at standards needed to prove value in the real world to secure access.
Read the full magazine here and see how to use the chaos as an opportunity: https://goo.gl/P7Ctkm
Key themes discussed:
• Embedding a culture of value in early development and how to engage scientists
• A win-win-win situation: Work with payers, regulators while always involving patients
• Boost your value story by identifying new and innovative end points that payers are interested in
Click here to download the magazine and learn how to embrace changes: https://goo.gl/P7Ctkm
eyeforpharma spoke with Teva, Otsuka, CSL Behring, and several more to hear how to manage these expectations whilst providing data at standards needed to prove value in the real world to secure access.
Read the full magazine here and see how to use the chaos as an opportunity: https://goo.gl/P7Ctkm
Key themes discussed:
• Embedding a culture of value in early development and how to engage scientists
• A win-win-win situation: Work with payers, regulators while always involving patients
• Boost your value story by identifying new and innovative end points that payers are interested in
Click here to download the magazine and learn how to embrace changes: https://goo.gl/P7Ctkm